About: Symptom Management and Supportive Care of Serious COVID-19 Patients and their Families in India

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Symptom Management and Supportive Care of Serious COVID-19 Patients and their Families in India Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Symptom Management and Supportive Care of Serious COVID-19 Patients and their Families in India
Creator	Bhatnagar, Sushma Salins, Naveen Gursahani, Roop Mani, Raj Simha, Srinagesh
Source	PMC
abstract	Coronavirus disease-19 (COVID-19) pandemic is causing a worldwide humanitarian crisis. Old age, comorbid conditions, end-stage organ impairment, and advanced cancer, increase the risk of mortality in serious COVID-19. A subset of serious COVID-19 patients with serious acute respiratory illness may be triaged not to receive aggressive intensive care unit (ICU) treatment and ventilation or may be discontinued from ventilation due to their underlying conditions. Those not eligible for aggressive ICU measures should receive appropriate symptom management. Early warning scores (EWS), oxygen saturation, and respiratory rate, can facilitate categorizing COVID-19 patients as stable, unstable, and end of life. Breathlessness, delirium, respiratory secretions, and pain, are the key symptoms that need to be assessed and palliated. Palliative sedation measures are needed to manage intractable symptoms. Goals of care should be discussed, and advance care plan should be made in patients who are unlikely to benefit from aggressive ICU measures and ventilation. For patients who are already in an ICU, either ventilated or needing ventilation, a futility assessment is made. If there is a consensus on futility, a family meeting is conducted either virtually or face to face depending on the infection risk and infection control protocol. The family should be sensitively communicated about the futility of ICU measures and foregoing life-sustaining treatment. Family meeting outcomes are documented, and consent for foregoing life-sustaining treatment is obtained. Appropriate symptom management enables comfort at the end of life to all serious COVID-19 patients not receiving or not eligible to receive ICU measures and ventilation. How to cite this article: Salins N, Mani RK, Gursahani R, Simha S, Bhatnagar S. Symptom Management and Supportive Care of Serious COVID-19 Patients and their Families in India. Indian J Crit Care Med 2020;24(6):435–444.
has issue date	2020-06-01(xsd:dateTime)
bibo:doi	10.5005/jp-journals-10071-23400
has license	cc-by-nc
schema:url	https://doi.org/10.5005/jp-journals-10071-23400
resource representing a document's title	Symptom Management and Supportive Care of Serious COVID-19 Patients and their Families in India
has PubMed Central identifier	PMC7435102
schema:publication	Indian J Crit Care Med
resource representing a document's body	covid:PMC7435102#body_text
is schema:about of	named entity 'COVID-19' named entity 'COVID-19' named entity 'Supportive Care' named entity 'India' named entity 'COVID-19' named entity 'intensive care' named entity 'morphine' named entity 'up/down' named entity 'breathlessness' named entity 'renally' named entity 'oxygen' named entity 'health workers' named entity 'up/down' named entity 'Middle East respiratory syndrome coronavirus' named entity 'palliative sedation' named entity 'morphine' named entity 'Personal protection equipment' named entity 'Nonsteroidal anti-inflammatory drugs' named entity 'COVID-19' named entity 'end-stage' named entity 'survivor’s guilt' named entity 'case fatality rate' named entity 'palliative sedation' named entity 'consciousness' named entity 'symptom' named entity 'parenteral' named entity 'lorazepam' named entity 'dyspnea' named entity 'Propofol' named entity 'haloperidol' named entity 'nasogastric tubes' named entity 'breathlessness' named entity 'maintenance dose' named entity 'COVID-19 hospitals' named entity 'physical restraints' named entity 'ICU' named entity 'COVID-19' named entity 'countrywide lockdown' named entity 'Haloperidol' named entity 'delirium' named entity 'midazolam' named entity 'Midazolam' named entity 'haloperidol' named entity 'opioids' named entity 'dexamethasone' named entity 'intensive care' named entity 'respiratory illness' named entity 'codeine' named entity 'blood-brain barrier' named entity 'end-organ' named entity 'healthcare providers' named entity 'authoritarianism' named entity 'hydration' named entity 'healthcare workers' named entity 'respiratory illness' named entity 'personal protective equipment' named entity 'Q8H' named entity 'consent form' named entity 'intensive care' named entity 'terminal illness' named entity 'Palliative care' named entity 'triage' named entity 'vomiting' named entity 'breathlessness' named entity 'emotional distress' named entity 'breathlessness' named entity 'WHO' named entity 'COVID' named entity 'glottis' named entity 'sleep-wake cycle' named entity 'Triage' named entity 'morphine' named entity 'triaging' named entity 'analgesic' named entity 'hydrocortisone' named entity 'risperidone' named entity 'depression' named entity 'critically ill patients' named entity 'prognostication' named entity 'Fentanyl'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software